Health Sciences Acquisitions 2

Health Sciences Acquisitions 2 was a healthcare-focused special purpose acquisition company formed to merge with or acquire a business in the health sciences sector. It was incorporated in 2020 as a Cayman Islands exempted company and completed an IPO on Nasdaq under the ticker HSAQ. The company did not operate a therapeutic pipeline, platform, or product business of its own; its principal activity was pursuing a business combination. In January 2023, it completed its merger with Orchestra BioMed, after which the SPAC ceased operating as an independent standalone public company. As a result, it is best characterized as a former healthcare-focused acquisition vehicle rather than an operating biotech or pharma company.